As Gambia Gov’t’s Coronavirus vaccine rollout is increasingly taking shape, the Director of Health, Dr. Mustapha Bittaye, has announced that people that are most at risk will be the leading targets of the vaccination campaign.
Speaking to this medium, Dr. Bittaye said health workers, the elderly and the most vulnerable will get the jab first.
Nearly 5,000 confirmed cases have been recorded in the country, and the total number of COVID-19 deaths has now reached 147.
The announcement made by Dr. Bittaye comes on the heels of a go-ahead issued by the Medicine Control Agency (MCA) for the use of AstraZeneca vaccine.
“Plans are advanced and we should receive the first batch soon,” Dr. Bittaye told this medium.
In December last year, a study conducted by The Lancet revealed that the Oxford-AstraZeneca has 90% efficacy in clinical trials, citing “investigators of four randomised, controlled trials conducted in the UK, South Africa, and Brazil.”
Describing the results as a ‘remarkable achievement’, The Lancet took the opportunity to shine a light on an “interim analysis of safety and efficacy against COVID-19 of the Oxford-AstraZeneca”.
Written by Abdoulie John
Join The Conversation